Literature DB >> 3136789

Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam.

M Sunzel1, L Paalzow, L Berggren, I Eriksson.   

Abstract

1. In the present study possible relationships between cardiovascular and respiratory effects and plasma concentrations were investigated after administration of midazolam and diazepam. Eight healthy volunteers were given three injections at 20 min intervals of equipotent sedative doses of midazolam (0.05 mg kg-1) and diazepam (0.15 mg kg-1) in a randomized double-blind cross-over design. Blood pressure, blood-gases and respiration measured nonivasively, were monitored throughout the experimental session of 160 min, and frequent blood samples were collected during the session. 2. Correlations between the blood pressure reduction, the increase of PaCO2 in blood, and plasma concentrations were found for both drugs. A maximal reduction of blood pressure and PaCO2 was produced after sedative doses of midazolam and diazepam. 3. A possible acute tolerance development towards the blood pressure reduction was found after the repeated administration of diazepam but not after the midazolam administration. 4. The plasma concentrations producing half the maximal effects after administration of midazolam was 50-60 ng ml-1, indicating that the influence on blood pressure and PaCO2 after drug administration is evoked at lower plasma concentrations than sedation. 5. No correlation between the respiratory effects and plasma concentrations was found for either drug.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136789      PMCID: PMC1386429          DOI: 10.1111/j.1365-2125.1988.tb03346.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Rapid micro-method for the measurement of diazepam and desmethyldiazepam in blood plasma by gas-liquid chromatography.

Authors:  D M Rutherford
Journal:  J Chromatogr       Date:  1977-07-21

2.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

4.  Recent advances in the evaluation of respiratory drive.

Authors:  J Milic-Emili
Journal:  Int Anesthesiol Clin       Date:  1977

5.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

Review 6.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

7.  [Relation between the clinical effect and the pharmacokinetics of midazolam following i.m. and i.v. administration/2nd comm.: Pharmacokinetical aspects (author's transl)].

Authors:  C Crevoisier; M Eckert; P Heizmann; D J Thurneysen; W H Ziegler
Journal:  Arzneimittelforschung       Date:  1981

8.  Changes in respiratory pattern after repeated doses of diazepam and midazolam in healthy subjects.

Authors:  L Berggren; I Eriksson; P Mollenholt; M Sunzel
Journal:  Acta Anaesthesiol Scand       Date:  1987-11       Impact factor: 2.105

9.  Evaluation of midazolam as an intravenous induction agent.

Authors:  J A Gamble; P Kawar; J W Dundee; J Moore; L P Briggs
Journal:  Anaesthesia       Date:  1981-09       Impact factor: 6.955

10.  Comparative cardiovascular effects of midazolam and thiopental in healthy patients.

Authors:  P W Lebowitz; M E Cote; A L Daniels; F M Ramsey; J A Martyn; R S Teplick; J K Davison
Journal:  Anesth Analg       Date:  1982-09       Impact factor: 5.108

View more
  16 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.

Authors:  Sangeeta Das; Kirsty Forrest; Simon Howell
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

3.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

Review 4.  Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil.

Authors:  R Amrein; W Hetzel
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 5.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions.

Authors:  B R Ogutu; C R J C Newton; J Crawley; S N Muchohi; G O Otieno; G Edwards; K Marsh; G O Kokwaro
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

7.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

8.  Use of bispectral index monitoring for a patient with hepatic encephalopathy requiring living donor liver transplantation: a case report.

Authors:  Hirobumi Okawa; Tomoko Ono; Eiji Hashiba; Toshihito Tsubo; Hironori Ishihara; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2010-12-03       Impact factor: 2.078

9.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

Review 10.  Pharmacokinetic-pharmacodynamic relationships for benzodiazepines.

Authors:  B E Laurijssens; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.